Horseradish Peroxidase Thumbnail Image

2024

Horseradish Peroxidase

Horseradish Peroxidase (HRP) Market , by Substrate (Chromogenic, Chemiluminescent, Others) , by Application (Immunoassays, Biosensors), by End User (Diagnostic Centers, Biopharmaceutical Companies, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

LS : Medical Devices & Supplies

Select an option
Author's: Shraddha Mali | Roshan Deshmukh
Publish Date:

Get Sample to Email

Horseradish Peroxidase (HRP) Market  Research, 2033

The global horseradish peroxidase (HRP) market was valued at $59.1 million in 2023, and is projected to reach $115.2 million by 2033, growing at a CAGR of 6.9% from 2024 to 2033. Rise in prevalence of chronic diseases and surge in the diagnosis is expected to drive the horseradish peroxidase (HRP) market.

Horseradish Peroxidase (HRP) Market 

Market Introduction and Definition 

Horseradish peroxidase (HRP) is an enzyme that is commonly extracted from the roots of the horseradish plant. It is widely used in biochemical research and diagnostic applications due to its ability to catalyze the oxidation of specific substrates in the presence of hydrogen peroxide (H₂O₂) , producing a detectable signal, such as a color change, light emission, or fluorescence. HRP facilitates the breakdown of hydrogen peroxide (H₂O₂) by transferring electrons from a substrate to hydrogen peroxide. This reaction leads to the formation of water and an oxidized substrate, which can then be detected by various methods. It is highly valued in research and diagnostic fields for its sensitivity, versatility, and stability, particularly in applications like Western blotting, ELISA, and immunohistochemistry. 

Key Takeaways 

  • The horseradish peroxidase (HRP) market size covers 20 countries. The research includes a segment analysis of each country in terms of value for the projected period. 
  • More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major horseradish peroxidase industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights. 
  • The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions in order to achieve their most ambitious growth objectives. 

Key Market Dynamics

The horseradish peroxidase (HRP) market growth is expected to witness surge owing to rise in prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases. HRP is a critical component in assays such as ELISA, which are commonly used to detect biomarkers associated with these conditions. The growing focus on research and development in the biotechnology and pharmaceutical industries has led to a higher demand for HRP in various applications, including protein detection, gene expression studies, and drug screening.

HRP is used in high-throughput screening assays for drug discovery, which is critical for identifying new therapeutic candidates. The expanding pipeline of biopharmaceuticals and personalized medicine is further driving the demand for HRP. Further, technological advancements in enzyme conjugation have resulted in more stable and specific HRP conjugates, enhancing the performance of assays in research and diagnostics. This has expanded the use of HRP in more complex and sensitive applications, thereby driving horseradish peroxidase (HRP) market growth.

The development of novel detection methods that utilize HRP for chemiluminescence, fluorescence, and colorimetric readouts has increased the versatility and application of HRP in various field. HRP is increasingly used in biosensors for point-of-care diagnostics, which require rapid and reliable detection of biomolecules. The trend towards decentralizing healthcare and providing testing solutions in non-laboratory settings is driving the demand for HRP-based biosensors, thereby driving horseradish peroxidase (HRP) market forecast.

The shift towards personalized medicine, which requires precise and tailored diagnostic tools, is driving the need for HRP in highly sensitive assays. The rapid growth of healthcare infrastructure in emerging markets, particularly in Asia-Pacific and Latin America, is driving demand for diagnostic reagents such as HRP. These regions are increasing their focus on improving healthcare access and outcomes, leading to greater adoption of HRP-based diagnostics. Thus, such factors are anticipated to drive the horseradish peroxidase (HRP) market size.

Parent Market Overview

Enzymes are biocatalysts that alter the reaction rate and produce the desired results in biological reactions. They are proteinaceous in nature and have gathered a special attention in recent years owing to their wide applications. Enzymes are employed in food and animal feed, textiles and detergents, pharmaceuticals and biotechnology R&D, manufacturing industries, and others (paper and pulp processing, leather processing and agriculture) . Their application in the manufacturing processes, resulting in significant cost reductions and limited energy consumption along with better substrate activity has contributed to the expansion of enzymes industry. The global enzymes market was valued at $5.8 billion in 2021, and is projected to reach $10.2 billion by 2031, growing at a CAGR of 6% from 2022 to 2031.

Global Enzymes Market, 2021-2031

2021

2031

5.8 billion

10.2 billion

Market Segmentation

The horseradish peroxidase (HRP) market analysis is segmented into substrate, application, end user, and region. On the basis of substrate, the market is categorized into chromogenic, chemiluminescent, and others. On the basis of application, the market is categorized into immunoassays and biosensors. On the basis of end user, the market is categorized into diagnostic centers, biopharmaceutical companies and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Regional/Country Market Outlook

North America accounted for a major horseradish peroxidase (HRP) market share of the horseradish peroxidase market owing to the presence of major players, advanced healthcare infrastructure, significant investment in research and development, presence of leading biotechnology and pharmaceutical companies, and high prevalence of diseases necessitating diagnostic testing. The high purchasing power, and a significant rise in capital income in developed countries are expected to drive the market growth.

Asia-Pacific horseradish peroxidase (HRP) market share is estimated to grow with the highest CAGR during the forecast period, owing to rise in prevalence of diseases, and surge in R & D investments. Another factor driving the growth of the market is focus of major players on technological advancements in horseradish peroxidase.

Industry Trends

  • There is a growing trend towards engineering HRP variants with enhanced properties, such as increased stability, higher activity, or altered substrate specificity.
  • HRP is being used in the development of biosensors for detecting various biomolecules, which are important in point-of-care diagnostics and environmental monitoring.

Competitive Landscape

The major players operating in the horseradish peroxidase (HRP) industry are Abcam Limited, Abnova Corporation, BBI Solutions, Bio-rad Laboratories, Inc., Creative Enzymes, Enzo Life Sciences, Inc., F. Hoffman-La Roche Ltd., Faizyme Laboratories (Pty) Ltd., GenScript, and Merck KGaA.

Key Sources Referred

  • National Center for Biotechnology Information
  • World Health Organization (WHO)
  • National Library of Medicine
  • The United States Food and Drug Administration
  • U.S. Department of Health & Human Services
  • Centers for Disease Control and Prevention
  • GOV.UK
  • Australian Institute of Health and Welfare

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the horseradish peroxidase (HRP) market analysis from 2024 to 2033 to identify the prevailing horseradish peroxidase (HRP) market opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the horseradish peroxidase (HRP) market  segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global horseradish peroxidase (HRP) industry.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global horseradish peroxidase (HRP) market trends, key players, market segments, application areas, and market growth strategies.

Horseradish Peroxidase Report Highlights

Aspects Details
icon_1
Market Size By 2033

USD 115.2 Million

icon_2
Growth Rate

CAGR of 6.9%

icon_3
Forecast period

2024 - 2033

icon_4
Report Pages

280

icon_5
By Substrate
  • Chromogenic
  • Chemiluminescent
  • Others
icon_6
By Application
  • Immunoassays
  • Biosensors
icon_7
By End User
  • Diagnostic Centers
  • Biopharmaceutical Companies
  • Others
icon_8
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
icon_9
Key Market Players

F. Hoffman-La Roche Ltd., Faizyme Laboratories (Pty) Ltd., BBI Solutions, Abcam Limited, Creative Enzymes, GenScript, Merck KGaA, Abnova Corporation, Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc.

Author Name(s) : Shraddha Mali | Roshan Deshmukh
Frequently Asked Questions?

Rise in prevalence of chronic diseases, and surge in diagnosis are the upcoming trends of Horseradish Peroxidase (HRP) Market  in the globe.

Immunoassay is the lucrative application of Horseradish Peroxidase (HRP) Market 

North America is the largest regional market for Horseradish Peroxidase (HRP) Market.

The global horseradish peroxidase (HRP) market was valued at $59.1 million in 2023, and is projected to reach $115.2 million by 2033, growing at a CAGR of 6.9% from 2024 to 2033.

The major players operating in the horseradish peroxidase market are Abcam Limited, Abnova Corporation, BBI Solutions, Bio-rad Laboratories, Inc., Creative Enzymes, Enzo Life Sciences, Inc., F. Hoffman-La Roche Ltd., Faizyme Laboratories (Pty) Ltd., GenScript, and Merck KGaA.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Horseradish Peroxidase

Global Opportunity Analysis and Industry Forecast, 2024-2033